Literature DB >> 30575921

MiR-410 regulates malignant biological behavior of pediatric acute lymphoblastic leukemia through targeting FKBP5 and Akt signaling pathway.

H-X Qi1, Q Cao, X-Z Sun, W Zhou, Z Hong, J Hu, C -X Juan, S Li, W-X Kuai.   

Abstract

OBJECTIVE: The aim of this study was to investigate the role of miR-410 in regulating the proliferation and apoptosis of pediatric acute lymphoblastic leukemia (ALL) cells and to explore the possible underlying mechanism. PATIENTS AND METHODS: The expression level of miR-410 in ALL cases and cells was detected by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR). Luciferase reporter gene assay was performed to evaluate the interaction between miR-410 and FKBP5. MTT and colony formation assay were used to determine the effect of miR-410 on the proliferation and colony formation ability of ALL cells. The effect of miR-410 on cell apoptosis was measured by Annexin V-fluorescein isothiocyanate 1 (FITC) and propidium iodide (PI). Western blot was used to analyze the effect of miR-410 on the protein expression levels of phosphorylated Akt (p-Akt) and cleaved caspase-3.
RESULTS: In our investigation, miR-410 was significantly up-regulated in ALL cases and cells. We searched three public databases to predict the potential target of miR-410, and found that FKBP5 was a direct target of miR-410. Meanwhile, Luciferase reporter gene assay confirmed our hypothesis. The overexpression of miR-410 accelerated the proliferation and colony formation ability of ALL cells, whereas remarkably decreased cell apoptosis rate. Western blotting showed that miR-410 inhibited the activation of Akt signaling pathway. However, FKBP5 could reverse the effects of miR-410.
CONCLUSIONS: MiR-410 regulated the proliferation, colony formation and apoptosis of ALL cells through targeting FKBP5 and Akt signal pathway, indicating that miR-410 might be a potential therapeutic target for the treatment of ALL.

Entities:  

Year:  2018        PMID: 30575921     DOI: 10.26355/eurrev_201812_16647

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Upregulating MicroRNA-410 or Downregulating Wnt-11 Increases Osteoblasts and Reduces Osteoclasts to Alleviate Osteonecrosis of the Femoral Head.

Authors:  Yukun Yin; Lixiang Ding; Yu Hou; Haoran Jiang; Ji Zhang; Zhong Dai; Genai Zhang
Journal:  Nanoscale Res Lett       Date:  2019-12-18       Impact factor: 5.418

2.  Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.

Authors:  Yvonne Saara Gladbach; Lisa-Madeleine Sklarz; Catrin Roolf; Julia Beck; Ekkehard Schütz; Georg Fuellen; Christian Junghanss; Hugo Murua Escobar; Mohamed Hamed
Journal:  Genes (Basel)       Date:  2022-07-14       Impact factor: 4.141

3.  MiRNA-181b-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis by Targeting SSX2IP in Acute Lymphoblastic Leukemia

Authors:  Xue Fu; Yuan He; Jun Song; Linhui Wang; Pengxiang Guo; Jun Cao
Journal:  Turk J Haematol       Date:  2022-06-06       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.